Moderna gets full U.S. approval for COVID vaccine in children 6 months and older
Moderna gets full U.S. approval for COVID vaccine in children 6 months and older | 10 July 2025 | The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the…